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cells or tissues through receptor-mediated interaction. However, most of the receptors are not exclusively overexpressed in cancer cells, resulting in compromised targeting efficiency. [4, 5] Dual-ligand targeting strategy has garnered increasing research interest over the past years. Several systems have been designed for consequentially targeting different cells or different cell compartments. Chen et al. [5] reported a dualligand nanoplatform (AuNC-cRGD-Apt) by conjugating gold nanocluster (AuNC) with a cyclic RGD (cRGD) peptide and an aptamer AS1411 (Apt) to consequentially target α v β 3 integrins overexpressed on tumor cell surfaces, and then nucleolin overexpressed in cytoplasm and nucleus of tumor cells. This AuNC-cRGD-Apt nanocarrier demonstrated high tumor specificity and deep tissue penetration. Xu et al. [6] developed hyperbranched amphiphilic copolymer (HPAE-co-PLA/DPPE) NPs functionalized with the RGD peptide (cRGDfK) and transferrin (Tf) to target tumor vasculature and tumor cells, respectively, showing enhanced in vitro cytotoxicity efficiency.
On the other hand, dual-ligand modified NPs can be designed to target two different receptors on the surface of the same cancer cell thus achieving a synergistic effect of the dual targeting as cancer cells often do not overexpress one but multiple surface receptors. Levine and Kokkoli [7] designed a PR_b peptide/ AG86 peptide dual-targeting heteromultivalent liposome system for gene delivery with the PR_b peptide targeting the overexpressed α 5 β 1 integrin and the AG86 peptide targeting the α 6 β 4 integrin. The optimized liposome formulation achieved efficient and selective transfection in the dual-receptor expressing cancer cells. Saul et al. [4] synthesized doxorubicinloaded liposomes decorated with two targeting ligands, that is, folic acid (FA) for folate receptor and a monoclonal antibody against the epidermal growth factor receptor (EGFR). The optimized dual-ligand formulation showed a threefold selectivity enhancement as compared to nontargeted liposomes, indicating its capability of achieving high toxicity in target cells having two receptors, while sparing those healthy cells with one or without any receptors. However, the dual-ligand strategy does not always live up to our high expectations. Some studies showed that dual-ligand targeting systems did not offer significant advantages over single-ligand formulations especially
The concept of dual-ligand targeting has been around for quite some time, but remains controversial due to the intricate interplay between so many different factors such as the choice of dual ligands, their densities, ratios and length matching, etc. Herein, the synthesis of a combinatorial library of single and dual-ligand nanoparticles with systematically varied properties (ligand densities, ligand ratios, and lengths) for tumor targeting is reported. Folic acid (FA) and hyaluronic acid (HA) are used as two model targeting ligands. It is found that the length matching and ligand ratio play critical roles in achieving the synergetic effect of the dual-ligand targeting. When FA is presented on the nanoparticle surface through a 5K polyethylene glycol (PEG) chain, the dual ligand formulations using the HA with either 5K or 10K length do not show any targeting effect, but the right length of HA (7K) with a careful selection of the right ligand ratio do enhance the targeting efficiency and specificity significantly. Further in vitro 3D tumor spheroid models and in vivo xenograft mice models confirm the synergetic targeting efficiency of the optimal dual-ligand formulation (5F2H 7K ). This work provides a valuable insight into the design of dual-ligand targeting nanosystems.
Introduction
Cancer remains one of the leading causes of death worldwide. Most cancer chemotherapies lack tumor specificity and cause severe side effects. [1] Targeted delivery of toxic chemotherapeutic drugs to cancer cells promises to improve drug effectiveness and reduce side effects. [2] Nanoparticles (NPs), as promising drug carriers, can prolong drug circulation time through optimizing their properties such as size, charge, and surface properties (e.g., PEGylation), thus promoting tumor-site accumulation by the enhanced permeability and retention (EPR) effect. [3] NPs can also be functionalized with targeting ligands to enhance their specific binding to cancer www.advancedsciencenews.com www.advhealthmat.de in in vivo models. [8] [9] [10] Sawant et al. [10] reported a dual-ligand poly(ethylene glycol)-phosphatidylethanolamine micelle system modified with Tf and monoclonal antibody (mAb) 2C5, but the dual-ligand formulation did not show enhanced effectiveness in vivo. They explained that further optimization of the ratio of these two ligands might be essential for their future studies.
Aside from the ratio of the two ligands, there are also many other factors affecting the targeting efficiency of dual-ligand formulations, such as particle size, charge, ligand density, affinity of ligands to receptors, etc., and careful optimization of these parameters is critical. Also, both transferrin and mAb 2C5 are large biomolecules, so they should be presented on the particle surface with the right conformation and orientation to retain their biological functions. Therefore, robust targeting ligands, such as small molecules or polysaccharides, are more appealing. FA [11] [12] [13] [14] [15] [16] is one of the most promising targeting ligands and has been extensively studied to target the FA receptor, which is overexpressed on many kinds of cancer cells including brain, breast, cervical, colorectal, epithelial, kidney, lung, and more than 90% ovarian cancer cells. [17] FA, as a small molecular targeting ligand, is cheap, nontoxic, stable, and easy to conjugate and characterize. Hyaluronic acid (HA), a natural polysaccharide, [18] [19] [20] [21] [22] has also attracted significant interest for targeted drug delivery. [23] HA binds to the CD44, which is overexpressed in several malignant tumor cells of high metastatic potency, such as breast, bladder, colon, esophageal, ovarian, and prostate cancers. [24] More interestingly, these two receptors (FA and CD44) have been reported to be co-overexpressed on several cancer types, such as breast and ovarian cancers. [25, 26] Liu et al. synthesized HA micelles conjugated with 6.8% of FA. [20, 27] Similarly, Lee et al. fabricated HA-ceramide NPs with 6.5% FA for the dual targeting. [28] At this instance, it is very hard to vary the density of HA on the particle surface. Wei Wang et al. prepared paclitaxel (PTX)-baicalein (BCL) NP drug-delivery system with dual ligands (FA and HA) for targeted delivery. The densities of the two ligands were varied, [29] and the size of HA was not mentioned. Furthermore, both experimental results [4, 7, 10] and computational simulation [8, 30] have demonstrated the critical roles of ligand density and ligand ratio, along with other factors, such as length matching of the two ligands and the interactions (e.g., hydrophobic interactions and electrostatic interactions) between the two ligands, in determining their dual-targeting efficiency. Therefore, it is crucial to prepare a combinatorial NP library with systematically varied parameters (ligand lengths, ratios, and densities) to screen the optimal dual-ligand formulation. [26] However, it remains a challenge to precisely control ligand density and ligand ratio by using traditional multiplestep postconjugation methods. [9] Here, we designed a dual-ligand targeting system with FA and HA as the two targeting ligands, to systematically study the effects of critical factors including ligand density, ratio, and length on in vitro and in vivo targeting efficiency. Biodegradable poly(d,l-lactic-co-glycolic acid) (PLGA) is a promising candidate to make NPs for drug delivery due to its unique properties such as biocompatibility, nontoxicity and versatile degradation kinetics. [31] PEGylation has been widely used to evade the immune system thus to achieve the long circulation time. [32] So, in this study, we self-assembled PLGA-PEG NPs to form a model NP. A combinatorial library of single and dualligand PLGA-PEG formulations with various ligand density, ratios, and lengths was prepared using a one-step microfluidic device. These libraries of NPs were systemically studied in vitro using 2D cell monolayer models to select the best single-ligand and dual-ligand formulations with highest targeting specificity. Three optimized formulations, including the optimal FA single-ligand formulation, the optimal HA single-ligand formulation, and the optimal dual-ligand formulation, were further investigated using 3D tumor spheroid models and a tumorbearing mouse model to compare their in vitro and in vivo tumor targeting efficiency with the untargeted PLGA-PEG NPs as the negative control. Also, as the length of HA is critical for their targeting efficiency, three different lengths of HA (5K, 7K, and 10K) were explored.
Results and Discussion

Design of the Dual-Ligand Targeting System
Our previous studies demonstrated that PLGA-PEG NPs can be synthesized using flow-focusing microfluidics with well-controlled size and surface properties by controlling the design of the microfluidic device, the flow rate ratio, the molecular weight of PLGA, and the concentration of PLGA ( Figure S1A , Supporting Information). [33] In this paper, we used PLGA-PEG with the molecular weight of 55K for PLGA and 5K for PEG. This combination of molecular weights allows the formation of NPs below 200 nm. Also, 5K PEG has been reported to have perfect steric effect and possible long circulation time. [34] To incorporate FA in the NPs, PLGA-PEG-FA was synthesized. By varying the initial ratio of PLGA-PEG-FA to PLGA-PEG, single-ligand targeting NPs with varied FA densities can be obtained. HA, as a polysaccharide, has various molecular weights that have been demonstrated to have significant effect on their targeting efficiency. Instead of conjugating HA on the particles surface, we conjugated HA directly with PLGA to get the polymer precursor PLGA-HA. The HA oligosaccharide with six monosaccharides (HA 6 ) is considered as the minimum oligomer size for effective binding to CD44 because a single binding site for the CD44/HA engagement can accommodate 6-10 sugar residues. HA with 6-18 monosaccharides (HA [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] ) may act as monovalent ligands for the CD44/ HA binding, while HA with 22-38 monosaccharides (HA [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] ) serves as multivalent ligands. [25] The bindings between CD44 and HA occur at the cell surface of CD44 positive cells, where the highly repeating disaccharide chains of HA can interact with multiple, closely arrayed receptors (CD44). The affinity of multivalent CD44/HA bindings is higher than that of the monovalent binding between CD44 and HA. [25] Based on these early theories, we selected HA oligosaccharides having defined sizes (M w ) of 5K (HA 5K ), 7K (HA 7K ), and 10K (HA 10K ) as the short, medium-length and long ligands to evaluate the effect of ligand length on dual-ligand targeting. The HA 5K , HA 7K , and HA 10K had about 26 monosaccharides (HA 26 ), 36 monosaccharides (HA 36 ), and 52 monosaccharides (HA 52 ), respectively. As the length of PEG is 5K, the minimum HA length should be longer than 5K so that it becomes accessible on the surface of the PLGA-PEG NPs.
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Experimental and computational studies [8, 30, 35] had investigated the interaction between NPs and cells, and found that when NPs came in contact with cells, they induced cell membrane deformation. Depending on how much the deformation is, NPs could be wrapped partially or completely by cell membranes. The specific binding between targeting ligands and cell surface receptors could enhance the wrapping process by increasing the engulfment degree or speeding up the deformation thus promoting faster cellular uptake. Because of the synergistic effect of two ligands, the specific binding of dual-ligand targeted NPs may be stronger than that of the single-ligand ones ( Figure 1A) . Therefore, we proposed a hypothetical mechanism for the dual-ligand targeted NP formulations having different lengths of HA ( Figure 1B) . The monovalent binding size of HA is about 6-18 monosaccharides (HA [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] ), [25] and the HA 5K (short ligand) has only 26 monosaccharides. Although the molecular weight of HA 5K is similar to that of the FA-PEG 5K , HA 5K is not accessible for its efficient binding to receptors (CD44) on the cell surface. For very long ligand (HA 10K ), its length is doubled the FA-PEG 5K , so the exposed extra sugar chain (HA 26 ) is long enough for multivalent binding, which would be optimal, but it may interfere with the FA thus leading to compromised binding efficiency.
For the medium-length ligand (HA 7K ) group (containing 36 monosaccharides), the exposed sugar chain is about 10-12 monosaccharide long. This exposed chain is enough for the optimal monovalent binding to the CD44, [25] so both ligands may target their receptors at the same time to achieve synergistic effects. Further in vitro and in vivo experiments were conducted to explore the effects of single-ligand densities, dual-ligands ratios, as well as HA lengths.
Synthesis and Characterization of Plain, Single, and Dual-Ligand NPs
Microfluidic Synthesis of Plain, Single, and Dual-Ligand NPs
The ligand conjugated polymers (HA 5K -PLGA, HA 7K -PLGA, HA 10K -PLGA, and FA-PEG 5K -PLGA) were synthesized by conjugating HA-NHS and FA-PEG 5K -NH 2 with PLGA-NH 2 and PLGA-NHS, respectively, using EDC/NHS chemistry (Figures S1B,C, Supporting Information). The HA-NHS was modified with PLGA-NH 2 using the random modification method due to the difficulties in carrying out selective modification on the end group of HA. In this case, the effective lengths for HA 5K , HA 7K , and HA 10K would be 2.5-5K, 3.5-7K, 5-10K, respectively, considering conditions where conjugation occurs in the middle of the chain. Therefore, they still have different exposed length and can be used to analyze the effect of ligand length. With this assumption, the exposed HA lengths (as the PEG is 5K) for HA 5K , HA 7K , and HA 10K groups are HA 0 , HA 0-12 , and HA 0-26 , respectively. The successful synthesis of these conjugated polymers was confirmed by 1 H-NMR and Fourier-transform infrared spectroscopy (FT-IR; Figure S2 , Supporting Information). In the 1 H NMR spectra, the peak (3) at 5.2 ppm corresponds to the CH protons of the PLA block; the peak (4) at 4.8 ppm corresponds to the CH 2 protons of the PGA block; and the peak (5) at 1.46 ppm corresponds to the methyl (3H, CH 3 ) of PLGA ( Figure S2A1 ,A2, Supporting Information). The characteristic peak (1) of the N-acetyl group and the peaks (2) of glucosidic H in the HA chain were detected at 1.80 and 2.85-4.55 ppm, respectively ( Figure S2A1 , Supporting Information). The conjugation efficiencies of HA-PLGA with three sizes (5K, 7K, and 10K) were all ≈75% based on the integral of the 1 H NMR spectra.
The 1 H NMR spectra of FA-PEG-PLGA ( Figure S2A2 , Supporting Information) and NH 2 -PEG-FA ( Figure S2A3 , Supporting Information) show similar peaks (peaks 6-13) with a characteristic peak (8) at 3.6 ppm corresponding to the CH 2 protons of the PEG block, and the characteristic peaks of FA at peaks (9) (10) (11) (12) representing the aromatic protons and pteridine proton of FA. The peak (6) at 3.3 ppm and the peak (7) at 2.5 ppm correspond to residual water and DMSO, respectively, as DMSO-d 6 was used as the solvent. However, the characteristic peaks (3-5) of PLGA can only be observed in the spectra of FA-PEG-PLGA, suggesting the existence of FA, PEG, and PLGA in the FA-PEG-PLGA sample. The conjugation efficiency of FA-PEG-PLGA was about 80% based on the integral of ( Figure S2C3 , Supporting Information) also demonstrated the successful conjugation of HA-NHS and PLGA-NH 2 . Figure 2 shows the flow-focusing microfluidic device for synthesizing the plain (PLGA-PEG), single-ligand (PLGA-PEG-FA, PLGA-PEG-HA), and dual-ligand (PLGA-PEG-FA/HA) NPs. Briefly, polymers and imaging agents were dissolved in a solvent. When this solvent phase introduced from the middle horizontal channel meets the water phase (either water or buffer solutions) from the vertical channels, a narrow stream forms in the middle of the channel. Because of the formation of the narrow polymer stream confined by the two side water streams, the rapid diffusion of solvent to the water phase decreases the solubility of the polymeric precursors significantly, thus precipitating the polymers out to form polymeric NPs. [31] Depending on the components in the solvent, different NPs can be produced. For example, to synthesize the dual-ligand formulation 5F2H 7K in the 7K HA group (5 mol% FA and 2 mol% 7K HA dual-ligand PLGA-PEG NPs), the solvent solution contained 93 mol% PLGA-PEG 5K , 5 mol% PLGA-PEG 5K -FA, 2 mol% PLGA-HA 7k copolymers, and DiI (20 µg mL −1 ). The DiI was used as the imaging agent for cellular uptake experiments. Based on this strategy, all of the plain, single, and dual-ligand NPs in this study were synthesized using this onestep hydrodynamic flow focusing method in the same microfluidic device. The density of PEG and targeting ligand (FA or HA) was tuned by changing the concentration ratio of the polymer precursors. The total concentration of the polymer precursors remained constant for all the experimental conditions, that is, 500 × 10 −3 m, while the concentration of fluorescent dye DiI was 20 µg mL −1 , and the flow rates of solvent and water were kept at 4 and 10 µL min −1 , respectively, for preparing all formulations.
Traditional methods for synthesizing dualligand NPs involve multiple steps, including particles synthesis, surface modification, PEGylation, and then conjugation of two targeting ligands consequentially, leading to the formation of dual-ligand NPs with uncontrolled surface properties (density and ratio of the two targeting ligands) and poor batch-to-batch reproducibility. In contrast to traditional multistep methods, we used a one-step microfluidic method to synthesize single and dual-ligand NPs libraries with precisely controlled and systematically varied properties, which is critical for screening the optimal dual-ligand formulations. [36] 
Nanoparticle Size and Surface Properties
Particle size and surface property play critical roles in affecting NPs' circulation time and in vivo fate. NPs with sizes ranging from 20 to 150 nm are considered as optimal for cancer drug delivery. [37] The plain, single-ligand, and dual-ligand NPs synthesized by the one-step microfluidic method were characterized using dynamic light scattering (DLS, Tables S1-S3, Supporting Information) and transmission electron microscopy (TEM; Figure 2 ). All the NPs had sizes around 70-90 nm, low polydispersity index (0.053-0.221), and slightly negative charge (−7.8 to −25.9 mV). Four NPs including the PLGA-PEG (plain NPs), 5F (5 mol% FA single-ligand NPs), 2H 7K (2 mol% 7K HA single-ligand NPs), and 5F2H 7K (5 mol% FA and 2 mol% 7K HA dual-ligand NPs) with medium HA length were observed under TEM. Figure 2 shows uniform and monodispersed NPs having spherical core-shell morphology, and dim lunar halo-like PEG layers can be observed around the PLGA cores. When looking more closely, we can find that the PEG layers of the PLGA-PEG NPs looked more dense and smooth than other three formulations that had jagged PEG layers, reflecting the different compositions of the PEG layer.
Effect of Ligand Density of the Single-Ligand Targeted NPs on Targeting Efficiency
We first synthesized FA single-ligand targeted NPs with five different FA molar ratios (molar concentration of FA-PEG-PLGA/ total polymer molar concentration) including 2, 5, 10, 20, and 30 mol%. To investigate the effect of the ligand density on monolayer cellular uptake, SKOV3 and MCF7 cell lines were used as the receptor positive and negative cell lines, respectively, based on the FA-receptor expression tests ( Figure S5A , Supporting Information). There have been contradictory reports about the FA-receptor expression level in MCF7 cells. Some researchers used MCF7 as an FA positive cell [27] while others used them as a negative control. [38, 39] Based on our results ( Figure S5A , Supporting Information), MCF7 cells had a negligible level of FAreceptor expression, so they were used as the negative control in our study. Macrophage cells are a type of white blood cells involved in innate immunity, and they recognize and destroy cell debris and foreign substances, such as pathogens and particles. Therefore, macrophage cells (RAW264.7) were used in this study to investigate the immune evasion capabilities of these NPs, which is critical for long circulation time thus offering a better chance to accumulate at the tumor sites. Figure 3 shows the flow cytometry results of the cellular uptake of the plain PLGA-PEG NPs, 2F (2 mol% FA), 5F, 10F, 20F, 30F, and with free FA inhibition. Cells incubated with culture medium without NPs were regarded as the blank. For the FA inhibition group, free FA was added along with the FA-targeted PLGA NPs at a concentration 1000 times higher. All the NPs in the FA single-ligand group had a relatively low RAW264.7 uptake, implying that the incorporation of FA ligand did not have adverse effects on their macrophage uptake, implying that the steric effect of the PEG on the particle surface which decreases nonspecific protein-protein interaction and nonspecific protein-cell interactions, while maintaining their colloidal stability under physiological conditions, was not comprised even in the presence of FA targeting molecules. [32, 40] The cellular uptake of the FA single-ligand NPs by MCF7 cells was similar to that of the plain PLGA-PEG NPs because the MCF7 cells do not have FA receptors on their surface. In contrast, the 2F, 5F, and 10F targeted formulations showed enhanced SKOV3 cellular uptake (p < 0.001) in comparison with the nontargeted plain NPs, and adding free FA inhibited the uptake to a similar level as that of the plain NPs, indicating the receptormediated endocytosis of the FA single-ligand NPs by the SKOV3 cells. Additionally, the significant increase in the SKOV3 cellular uptake was only observed for the FA density in the range of 2-10 mol%. Further increasing the FA density to 20 or 30 mol% adversely affected the uptake to a minimum level at 30 mol% (only 49% increase than the plain NPs). These results were consistent with Kang et al.'s work on FA-targeted liposomes. They also found an optimum FA density, and further increasing the FA density, on the contrary, decreased the cellular uptake. [41] Therefore, three ligand densities, that is, 2, 5, and 10 mol%, were selected for further studies.
Optimization of Ligand Ratio and Ligand Length for the Dual-Ligand Targeted NPs
As aforementioned, SKOV3 was used as the FA-receptor-positive cell line, and MCF7 and RAW264.7 were used as the negative controls in this study. We further tested the expression of CD44 on these three cell lines. SKOV3 cells showed a high level of CD44 expression (with 68 times increase; Figure S5B , Supporting Information), whereas RAW264.7 and MCF7 cells demonstrated relatively low (with only 7 times increase) and negligible expression levels of CD44, respectively. Therefore, SKOV3 cells were used as the double positive cells for both FA and HA receptors; RAW264.7 cells were used as the single positive cells; and MCF7 cells were used as the double negative cells. We hypothesize that an optimal dual-ligand formulation can achieve optimal targeting specificity, that is, to achieve the maximum cell uptake for double positive cells (FA receptor and CD44 positive SKOV3 cells) and minimum cell uptake for single positive RAW264.7 cells and double negative MCF7 cells. As the molecular weight of HA is important, short, mediumlength, and long HA ligand were studied. To find the best formulation, we compared three FA single-ligand NP formulations (2F, 5F, and 10F), three HA single-ligand NP formulations (2H, 5H, and 10H), and nine dual-ligand NP formulations with different FA/HA molar ratios (2F2H, 2F5H, 2F10H, 5F2H, 5F5H, 5F10H, 10F2H, 10F5H, and 10F10H 
Short Ligand (HA 5K ) Group
First, the short ligand HA 5K group was investigated. Figure S6 , Supporting Information).
Long Ligand (HA 10K ) Group
We also used 10K HA to study the effect of long ligand on their cellular uptake ( Figure 4B ). For the HA 10K single-ligand formulations (2H 10K , 5H 10K , and 10H 10K ), the cellular uptake by all the three types of cells decreased with the increasing HA concentration from 2 to 10 mol%, and all the three cells had similar level of cellular uptake. None of the dual-ligand formulations exhibited targeting effects in comparison with the FA single-ligand formulations. For all the dual-ligand formulations in this group, their cellular uptakes by SKOV3 cells were much lower than all the FA single-ligand formulations, indicating the negative interactions between the FA ligands and the long chain HA, thus making the FA ligands unable to bind to the FA receptors on the SKOV3 cells. Interestingly, the 5F10H 10K (257% of the plain PLGA-PEG), 10F5H 10K (238.4%), and 10F10H 10K (245.9%) formulations were taken up more efficiently by the MCF7 cells. It may be due to the high expression of hyaluronidase (Hyal1) on the breast cancer cell line (MCF7), which can act as a target. [36] It is also interesting to find that the internalization of 5F10H 10K by MCF7 cells was significantly higher than that of 10H 10K and 2F10H 10K . For this long ligand (HA 10K ) group, the interactions between HA 10K molecules with long chains become stronger when its concentration increases, weakening the hyaluronidase mediated binding to the MCF-7 cells. Therefore, we found that the internalization of 10H 10K was lower than that of 2H 10K . However, the presence of FA on the interface interferes the interaction between HA 10K molecules. Therefore, the two formulations with higher concentrations of FA (10F10H 10K and 5F10H 10K , no significant difference between these two groups) exhibited more internalization than that of the formulation Adv. Healthcare Mater. 2018, 7, 1800106 Figure 4. Cellular uptake of the DiI-labeled plain, single, and dual-ligand NPs by MCF7, SKOV3, and RAW264.7 cells for A) short ligand (HA 5K ) group, B) long ligand (HA 10K ) group, and C) medium-length ligand (HA 7K ) group. ***, **, * represent statistically significant difference (p < 0.001, p < 0.01, and p < 0.05). N.S. represents no statistically significant difference (mean ± SD, n = 3).
www.advancedsciencenews.com www.advhealthmat.de with a lower concentration of FA (2F10H 10K ). Based on our results, the bindings between HA 10K and hyaluronidase might only happen when the HA and FA densities on the NP surface were high enough, and the HA chain was long enough. Thus, HA 10K is not the ideal length for the dual-ligand targeting.
Medium-Length Ligand (HA 7K ) Group
We further investigated a medium molecular weight of 7K ( Figure 4C ). For the HA 7K single-ligand formulations (2H 7K , 5H 7K , and 10H 7K ), the trend of their SKOV3 cellular uptake was similar to the FA single-ligand formulations. After achieving the maximum cellular uptake using the HA molar ratios of 2% and 5% (2H 7K , 5H 7K ), further increasing the ratio to 10 mol% decreased the uptake. While for the MCF7 and RAW264.7 cells, the cellular uptake increased with the HA molar ratio, and the maximum uptake was at 10% (10H 7K ). This is mainly due to the different CD44's densities on these three cells, and the cells with higher CD44 density need fewer HA ligands to form effective binding. 2H 7K was the optimum HA singleligand formulation for the SKOV3 cells in the medium-length ligand group. For the dual-ligand formulations, 5F2H 7K showed the best specificity with the highest SKOV3 uptake (313.6%), greater than both of the 5F (242.1%) and 2H 7K (216.3%). The cellular uptake of 5F2H 7K by MCF7 and RAW264.7 was 79.2% and 90.8%, respectively, lower than 5F (84.1% and 111.2%) and 2H 7K (122% and 124.5%).
In this medium-length ligand group, the 5F2H 7K formulation was demonstrated to be able to achieve the best synergetic effect of targeting specificity: low uptake by the single positive (macrophage) and double negative (MCF7) cells, and high specificity to the double positive SKOV3 cells. As the CD44 density on the surface of RAW264.7 cells is relatively low, the monovalent CD44/HA binding is weak. With the strong steric repulsive effect from the high density of PEG as well as the small ratio of the HA (2%), a negligible RAW264.7 cell uptake was achieved. While for the SKOV3 cells, the extremely high density of FA receptors/CD44 on the cell surface renders the strong and specific targeting effect. Also, for all the dual-ligand formulations in this group, their cell uptake by SKOV3 cells was much higher than that of the same formulations in short ligand (HA 5K ) and long ligand length (HA 10K ) groups. It suggested that the synergistic effect of FA and HA only occurred at the dual-ligand formulations with the appropriate HA length, which demonstrates the critical role of the HA length as well as the molar ratio of the two targeting ligands. These results validated our hypothesis about the critical role of ligand lengths and ligand ratios in dual-ligand targeting (Figure 1 ).
Tumor Spheroids Uptake
Tumor spheroids are aggregates of tumor cells grown in a suspension or embedded in a 3D matrix. They possess some characteristics that 2D cell culture models lack, such as extracellular matrix, cell-cell interactions, spatial geometry, and a necrotic core similar to poorly vascularized tumors. Therefore, 3D spheroid uptake can provide more in vivo relevant information. [42, 43] Based on the monolayer cellular uptake results (Figure 4) , four NP formulations, plain (PLGA-PEG) NPs, 5F (optimal FA single-ligand formulation), 2H 7K (optimal HA single-ligand formulation), and 5F2H 7K (optimal FA-HA dual-ligand formulation) were selected and further investigated using the 3D tumor spheroid model. The HA used in these formulations is HA 7K . The size of tumor spheroids is crucial because it is associated with cell function, drug transport, and penetration. [42] Large spheroids (200-500 µm) can form gradients of oxygen, nutrients, and catabolites, which are the key features of tumors in vivo. Therefore, MCF7 and SKOV3 tumor spheroids of 400 µm in diameter were prepared to conduct the 3D cellular uptake study. Figure 5A ,B shows the uptake results of the four NP formulations in the MCF7 and SKOV3 tumor spheroids, respectively. Overall, the MCF7 tumor spheroids had much less uptake than the SKOV3 spheroids. The single-ligand formulations (5F and 2H 7K ) were taken up 2 times more by the SKOV3 spheroid in comparison with the plain (PLGA-PEG) formulation. Moreover, the dual-ligand formulation 5F2H 7K demonstrated a fourfold increase of uptake and penetrated as deep as 60 µm. Layer-by-layer scanning also exhibited that all targeted formulations had increased accumulation compared to the plain formulation in the SKOV3 spheroid, but not for the MCF7. More specifically, each layer of the 5F2H 7K formulation displayed the strongest signal (maximum NPs' accumulation) compared to the same depth layer of the other three formulations in SKOV3 tumor spheroids ( Figure S7 , Supporting Information). Consistent with the confocal results ( Figure 5C ), the flow cytometry results illustrated that the dual-ligand formulation 5F2H 7K had a significantly higher (p < 0.001) uptake by the SKOV3 tumor spheroids, but not the MCF7. These results confirmed the excellent specificity of the dual-ligand targeted formulation 5F2H 7K .
In vivo Tumor Targeting Efficiency of the Single-and DualLigand Formulations
To evaluate the in vivo tumor targeting efficiency of the optimal single-and dual-ligand formulations, a SKOV3 xenograft tumor model was established using female BALB/c nude mice. Figure 6 shows the in vivo fluorescence images of DiR-loaded plain (PLGA-PEG), optimal single-ligand (5F, 2H 7K ), and dualligand (5F2H 7K ) formulations in SKOV3 tumor-bearing mice after tail vein injection of the NPs. The time elapsed whole animal images showed the distribution of the NPs at 2, 6, 12, 24, and 48 h, respectively. Because of the rapid circulation of the NPs in the bloodstream, clear DiR signals were detected at 2 h. For all the time points up to 72 h, the majority of the NPs accumulated in the spleen, liver, and tumor after intravenous administration for all the four formulations (PLGA-PEG, 5F, 2H 7K , and 5F2H 7K ). The fluorescence intensity (FI) in tumors for all the targeted groups (5F, 2H 7K , and 5F2H 7K ) was significantly higher (p < 0.05) than that of the plain PLGA-PEG group from 2 to 48 h (Figure 7) . More specifically, from 2 to 24 h, the mean FI for tumors of the 5F2H 7K group was significantly higher (p < 0.05) than the plain (PLGA-PEG) and singleligand (5F and 2H 7K ) groups, which confirmed the best tumor targeting efficiency of the dual-ligand formulation 5F2H 7K .
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At 12 h, the mean FI of the 5F group achieved the maximum level. However, the PLGA-PEG, 2H 7K and 5F2H 7K groups achieved the maximum level at 24 h. At 24 h, the mean FI of the 5F2H 7K group was 2.6 times of the PLGA-PEG group, while the mean FI of 5F and 2H 7K group was 1.63 and 1.68 times of the PLGA-PEG group, respectively. This result is very similar to the result of SKOV3 tumor spheroid uptake at 24 h, implying that 3D spheroids can serve as a valuable model for providing in vivo relevant information. After reaching the highest FI, the signals in tumors of all groups gradually decreased except that the signal of 5F group decreased very slowly because of the strong interactions between the FA ligands and the FA receptors on the SKOV3 cancer cells. For all the time points, the 5F2H 7K group has the highest tumor accumulation among all groups, showing the best tumor targeting efficiency. The ex vivo fluorescent images of the excised organs and tumors further confirmed that the NPs mostly accumulated in the liver, spleen, and tumors. In excised tumors, highest FI was observed for the 5F2H 7K group among all groups at each time point ( Figure S8, Supporting Information) . Furthermore, the in vivo tumor to liver ratio and the tumor to spleen ratio of the 5F2H 7K were higher than that of the plain and singleligand formulations (PLGA-PEG, 5F, and 2H 7K ). This result corresponds well with the 2D and 3D in vitro results (Figure 7) . The in vivo results confirmed the improved targeting efficiency of the dual-ligand 5F2H 7K formulation again. Therefore, it is very critical to design the dual-targeting NPs with the appropriate ligand ratio and the good matching of the ligand lengths to achieve enhanced targeting efficiency and specificity.
Conclusions
In this work, we successfully developed a dual-ligand targeting nanosystem for enhanced targeting efficiency and specificity, based on the systematic study of the ligand density, ligand ratio, and ligand length. The one-step microfluidic hydrodynamic flow focusing technology allows us to synthesize libraries of NPs with systematically varied properties including single-ligand formulations (FA, HA) and dual-ligand formulations with well-controlled size, surface properties, ligand density, and ligand ratio. To the best of our knowledge, this is the first report of a systematic study on the ligand ratio and ligand length effect of the dual-ligand systems on targeted drug delivery. It is also the first report of using a simple microfluidic device to synthesize a combinatorial library of dual-ligand targeted NPs with precisely controlled properties. The length of the HA and the ratio of the two targeting ligands are critical factors to achieve the optimum targeting specificity. Additionally, the studies using 3D in vitro tumor spheroid model and in vivo mice model also demonstrated that the optimal dual-ligand formulation (5F2H 7K ) exhibited the highest tumor targeting efficiency compared to the optimized single-ligand formulations (5F and 2H 7K ) and plain formulation (PEG). However, we have not fully understood the mechanism underlying the dual-ligand targeting due to the incomplete understanding of the complicated interactions between the two targeting ligands and the receptors on the cell surface. This complexity is even compounded when the targeting ligands have different densities and lengths. This warrants further investigation in our future works. Nevertheless, this study provides valuable insight into the design of dual-ligand targeting drug delivery systems, and also offers a strategy to develop libraries of nanoformulations with systematically designed properties.
Supporting Information
Supporting Information is available from the Wiley Online Library or from the author. C) The tumor to spleen (T/S) ratio for DiR-labeled PLGA nanoparticles in SKOV3 tumor-bearing female nude mice after tail vein injection of the formulations at predetermined time intervals. ***, **, * represent statistically significant difference (p < 0.001, p < 0.01, and p < 0.05). N.S. represents no statistically significant difference (mean ± SD, n = 3).
